ADGRF1 and Hepatic steatosis: Based on the dramatic difference in expression levels of hepatic ADGRF1 before and after HFD treatment, we hypothesized that downregulation of Adgrf1 in HFD-fed mice may be involved in the pathogenesis of fatty liver.